Processing

Please wait...

Settings

Settings

1. WO2000039588 - DETECTION OF PREACTIVATED PHAGOCYTES

Publication Number WO/2000/039588
Publication Date 06.07.2000
International Application No. PCT/NL1999/000806
International Filing Date 24.12.1999
Chapter 2 Demand Filed 17.07.2000
IPC
A61K 35/76 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
76Viruses; Subviral particles; Bacteriophages
G01N 33/569 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
CPC
C12N 2795/00032
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
00032Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N 7/00
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
G01N 33/56972
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
56966Animal cells
56972White blood cells
Applicants
  • GLAXOWELLCOME B.V. [NL/NL]; Huis ter Heideweg 62 NL-3705 LZ Zeist, NL (AllExceptUS)
  • KOENDERMAN, Leendert [NL/NL]; NL (UsOnly)
  • LOGTENBERG, Ton [NL/NL]; NL (UsOnly)
  • RAAIJMAKERS, Johannes, Antonius, Maria [NL/NL]; NL (UsOnly)
Inventors
  • KOENDERMAN, Leendert; NL
  • LOGTENBERG, Ton; NL
  • RAAIJMAKERS, Johannes, Antonius, Maria; NL
Agents
  • ALTENBURG, Bernardus, Stephanus, Franciscus; Octrooibureau Los en Stigter B.V. Weteringschans 96 NL-1017 XS Amsterdam, NL
Priority Data
101089324.12.1998NL
101134119.02.1999NL
Publication Language English (EN)
Filing Language Dutch (NL)
Designated States
Title
(EN) DETECTION OF PREACTIVATED PHAGOCYTES
(FR) DETECTION DE PHAGOCYTES PREACTIVES
Abstract
(EN)
The present invention relates to an antigen of a phagocyte. The antigen according to the invention is specific for a preactivated phagocyte and can be recognized by at least one bacteriophage as can be isolated from the strains having accession numbers CBS 101481 and 101482. The invention also relates to a phagocyte-recognizing agent recognizing an antigen specific for a preactivated phagocyte, as well as a pharmaceutical compound comprising such an agent. Finally the invention relates to a method of detecting a preactivated phagocyte using a phagocyte-recognizing agent according to the invention.
(FR)
L'invention concerne un antigène d'un phagocyte. Cet antigène est spécifique d'un phagocyte préactivé et peut être reconnu par au moins un bactériophage de façon à être isolé des souches de numéros d'entrée CBS 101481 et 101482. L'invention concerne également un agent d'identification du phagocyte qui identifie un antigène spécifique d'un phagocyte préactivé, ainsi qu'un composé pharmaceutique contenant cet agent. L'invention concerne enfin un procédé de détection d'un phagocyte préactivé au moyen de l'agent identifiant le phagocyte.
Also published as
US09869208
Latest bibliographic data on file with the International Bureau